Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 167Leukemia 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Lymphoma 51Myelodysplastic Syndromes 38Congenital Abnormalities 32Burkitt Lymphoma 29Lymphoma, Non-Hodgkin 27Recurrence 26Leukemia, Myelomonocytic, Acute 26Leukemia, Monocytic, Acute 26Lymphoma, Mantle-Cell 23Leukemia, Erythroblastic, Acute 23Leukemia, Megakaryoblastic, Acute 21Hodgkin Disease 18Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Follicular 13Myeloproliferative Disorders 12Leukemia, Myelomonocytic, Chronic 11Leukemia, Biphenotypic, Acute 11Leukemia, Eosinophilic, Acute 9Blast Crisis 9Lymphoma, B-Cell 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Anemia, Refractory, with Excess of Blasts 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 7Multiple Myeloma 7Leukemia, Basophilic, Acute 7Leukemia, Lymphocytic, Chronic, B-Cell 6

Interventions

Tretinoin 5Methotrexate 5Tacrolimus 4Arsenic Trioxide 4fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Busulfan 3Mycophenolic Acid 2Mercaptopurine 2Idarubicin 2Gemtuzumab 2Filgrastim 2Cytarabine 2Cyclophosphamide 2Antilymphocyte Serum 2thymoglobulin 1entinostat 1Whole-Body Irradiation 1Vorinostat 1Sorafenib 1Sirolimus 1Granulocyte Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Daunorubicin 1Clofarabine 1Bortezomib 1Biopsy 1Azacitidine 1Alemtuzumab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, Promyelocytic, Acute × Cytarabine × Clear all
NCT01253070 2022-08-04

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00602225 2018-03-09

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

University of Washington

Phase 1/2 Completed
50 enrolled 13 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡